A study of symptoms described by ovarian cancer survivorsChara Stavraka, Sarah P. Blagden, Amy Ford et al.|Gynecologic Oncology|2011Cited by 94
Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancerV Harding, Roshan Agarwal, Elisabetta Fenu et al.|British Journal of Cancer|2012Cited by 34
A Study to Evaluate the Cause of Bone Demineralization in Gynecological Cancer SurvivorsChara Stavraka, Sarah P. Blagden, Kate Maclaran et al.|The Oncologist|2013Cited by 27
Dose-Finding Quantitative <sup>18</sup>F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic MalignanciesHatice Güngör, Hani Gabra, Nona Rama et al.|Journal of Nuclear Medicine|2015Cited by 27
Intravenous Versus Oral Dexamethasone Premedication in Preventing Paclitaxel Infusion Hypersensitivity Reactions in Gynecological MalignanciesSéan M. O’Cathail, Roshan Agarwal, Roekshana Shaboodien et al.|International Journal of Gynecological Cancer|2013Cited by 16